Subcategory & Sub-subcategory
Specifications
- Formulation Type: Lipid nanoparticle (LNP) formulation using the proprietary STLNP platform with a novel ionizable lipid, applied to linear mRNA and circular RNA drug substances.
- Certification Standard: Manufactured in both GMP and non-GMP grades, supporting the full process up to an IND-enabling package (AMD, CMC, etc.).
- Application: Custom mRNA in vitro transcription (IVT) synthesis through LNP formulation for mRNA vaccines and therapeutics, covering linear mRNA and circular RNA (eGFP, Fluc, hEPO) at IVT scales up to 160 g and LNP formulation above 1 g.
- Country of Origin: Korea, Republic of.
Leave your rating & comment